Fagron N.V.
FAGR | BR
Overview
Corporate Details
- ISIN(s):
- BE0003874915
- LEI:
- 549300TRKRUFK2RRG779
- Country:
- Belgium
- Address:
- Venecoweg 20A, 9810 Nazareth
- Website:
- https://fagron.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Fagron is active in 35 countries in EMEA, North America, and Latin America. Fagron has sterile and non-sterile compounding facilities in Europe (the Netherlands, Belgium, and the Czech Republic), Israel, the United States, Colombia, and South Africa, which supply medications to pharmacies, hospitals, and clinics, as well as directly to patients in South Africa and Colombia. With over 400 pharmacists within Fagron, we are focused on providing a unique range of high-quality products based on scientific data and insights. The Fagron Brands are unique concepts developed by our R&D specialists to provide pharmacies and clients with exclusive pharmaceutical dosage forms and active pharmaceutical ingredients (APIs). We can provide solutions for all steps inside a compounding setting, either equipment, excipients, APIs, packaging, and much more.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-09 08:27 |
Declaration of Voting Results & Voting Rights Announcements
Fagron increases share capital through exercise subscription rights
|
English | 93.1 KB | |
| 2025-06-09 08:27 |
Declaration of Voting Results & Voting Rights Announcements
Fagron increases share capital through exercise subscription rights
|
Dutch | 398.4 KB | |
| 2025-06-06 19:00 |
Declaration of Voting Results & Voting Rights Announcements
250606 - Press release increase share capital 6 June 2025.pdf
|
English | 93.1 KB | |
| 2025-06-06 19:00 |
Declaration of Voting Results & Voting Rights Announcements
250606 - Persbericht verhoging kapitaal 6 juni 2025.pdf
|
Dutch | 94.7 KB | |
| 2025-04-11 08:00 |
Regulatory News Service
250411_Fagron publishes agenda for 2025 annual shareholders meeting.pdf
|
English | 79.6 KB | |
| 2025-04-11 08:00 |
Regulatory News Service
12 May 2025 - Convocation AGM 12 May 2025.pdf
|
English | 157.9 KB | |
| 2025-04-11 08:00 |
Regulatory News Service
12 mei 2025 - Volmacht AVA 12 mei 2025.pdf
|
Dutch | 299.5 KB | |
| 2025-04-11 08:00 |
Regulatory News Service
12 May 2025 - Proxy AGM 12 May 2025.pdf
|
English | 287.5 KB | |
| 2025-04-11 08:00 |
Regulatory News Service
12 mei 2025 - Oproeping AVA 12 mei 2025.pdf
|
Dutch | 243.6 KB | |
| 2025-04-11 08:00 |
Regulatory News Service
250411_Fagron publiceert agenda jaarlijkse aandeelhoudersvergadering 2025.pdf
|
French | 83.2 KB | |
| 2025-04-10 07:00 |
Quarterly Report
Recordomzet van € 239 miljoen in het eerste kwartaal, wat een omzetgroei van 14…
|
Dutch | 226.1 KB | |
| 2025-04-10 07:00 |
Regulatory News Service
Record first-quarter revenue of €239 million, reflecting 14% topline growth .pdf
|
English | 229.8 KB | |
| 2025-04-10 07:00 |
Inside Information Statement
Recordomzet van € 239 miljoen in het eerste kwartaal, wat een omzetgroei van 14…
|
Dutch | 226.1 KB | |
| 2025-03-06 00:00 |
Regulatory News Service
Jaarverslag-2024.pdf
|
Dutch | 11.6 MB | |
| 2025-03-06 00:00 |
Regulatory News Service
Annual-report-2024.pdf
|
English | 11.3 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-23 | Pulido Andrew | Executive member | Sell | 85,000 | 1,803,351.50 EUR |
| 2025-05-22 | Pulido Andrew | Executive member | Buy | 85,000 | 1,617,550.00 EUR |
| 2025-05-02 | De Jong Cornelia Neeltje | Board | Sell | 12,689 | 263,834.55 EUR |
| 2025-04-30 | De Jong Cornelia Neeltje | Board | Sell | 229 | 4,660.15 EUR |
| 2025-04-29 | De Jong Cornelia Neeltje | Board | Sell | 10,000 | 201,500.00 EUR |
| 2025-03-28 | J. Verlinden | Other | Buy | 24,551 | 453,702.48 EUR |
| 2025-03-28 | J. Verlinden | Other | Sell | 17,930 | 344,047.56 EUR |
| 2025-03-27 | Padilla Rafael | Board | Buy | 78,469 | 1,450,107.12 EUR |
| 2025-03-27 | De Jong Cornelia Neeltje | Board | Buy | 45,418 | 839,324.64 EUR |
| 2025-02-21 | Bakker Vera | Executive member | Buy | 773 | 15,000.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Flerie AB | Sweden | FLERIE | |
|
Friulchem | Italy | FCM | |
|
FRP ADVISORY GROUP PLC | United Kingdom | FRP | |
|
Galderma Group AG | Switzerland | GALD | |
|
GlaxoSmithKline PLC | United Kingdom | GSK | |
|
Gour Medical | France | MLGML | |
|
Grifols S.A. | Spain | GRF | |
|
Guerbet | France | GBT | |
|
Haemato AG | Germany | HAEK | |
|
Halychpharm | Ukraine | GFARM |